샘플 요청 목록

 카트 문의
시장보고서
상품코드
1784913

세계의 미용 주사 시장

Aesthetic Injectables
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 212 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미용 주사 세계 시장은 2030년까지 273억 달러에 달할 전망

2024년에 157억 달러로 추정되는 미용 주사 세계 시장은 2030년에는 273억 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 9.6%로 성장할 것으로 예측됩니다. 보툴리눔톡신(보톡스) 미용 주사는 이 보고서에서 분석한 부문 중 하나로 CAGR 11.1%를 기록하며 분석 기간 종료시에는 180억 달러에 달할 것으로 예측됩니다. 더말 필러 미용 주사 부문의 성장률은 분석 기간 동안 CAGR 7.1%로 추정됩니다.

미국 시장은 41억 달러로 추정, 중국은 CAGR 9.2%로 성장 예측

미국의 미용 주사 시장은 2024년에 41억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 43억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 9.0%와 8.0%로 예측됩니다. 유럽에서는 독일이 CAGR 7.6%로 성장할 것으로 예측됩니다.

세계의 미용 주사 시장 - 주요 동향과 촉진요인 정리

미용 및 건강 산업에서 미용 주사 수요가 급증하는 이유는 무엇일까?

소셜 미디어의 영향과 미의 기준의 진화로 인해 개인의 외모와 자기 관리에 대한 관심이 높아지면서 미용 주사에 대한 수요가 크게 증가하고 있습니다. 얼굴의 미관을 개선하고 노화의 징후를 늦추기 위해 최소침습적인 미용성형을 찾는 사람들이 늘고 있으며, 미용 주사는 젊은 층부터 노년층까지 폭넓게 받아들여지고 있습니다. 보톡스, 필러, 기타 주사제는 더 이상 연예인이나 고소득층에게만 국한된 것이 아니라, 저렴한 가격과 접근성으로 인해 보다 폭넓은 소비자층으로 그 범위가 확대되고 있습니다. 또한, 소비자들이 젊은 피부를 유지하기 위해 조기 개입 치료를 선택하는 예방 미용에 대한 인식이 높아지면서 시장 성장의 원동력이 되고 있습니다. 가처분 소득의 증가와 비수술적 대체 의학으로의 전환과 함께 미용 강화에 대한 수용이 증가함에 따라 다양한 지역에서 미용 주사에 대한 수요가 더욱 증가하고 있습니다.

기술 발전과 제품 혁신이 시장을 어떻게 변화시키고 있는가?

제형기술과 주입기술의 발전은 미용 주사 시장에 혁명을 가져왔고, 시술을 보다 안전하고 효과적이며 오래 지속되도록 했습니다. 히알루론산 기반 필러, 수명이 길어진 보툴리눔톡신, 콜라겐 생성을 촉진하는 바이오 시뮬레이터를 특징으로 하는 차세대 필러는 소비자와 시술자 모두에게 사랑받고 있습니다. 이러한 기술 혁신은 보다 자연스러운 마무리를 가져와 과잉치료에 대한 우려를 줄이고 환자 만족도를 높이고 있습니다. 또한, 마이크로 캐뉼라나 바늘을 사용하지 않는 주사 시스템의 등장으로 정확도가 향상되고, 불편함을 최소화할 수 있어 이러한 시술을 선택하는 사람들이 더욱 늘어나고 있습니다. 미용 상담에 인공지능(AI)과 3D 영상 기술의 통합은 환자의 경험을 변화시키고, 시술자가 더 높은 정확도로 치료 계획을 맞춤화할 수 있게 해줍니다. 지속시간 연장, 질감 개선, 부작용 감소에 초점을 맞춘 지속적인 제품 개발로, 시장은 다양한 소비자 취향에 부합하는 혁신적인 솔루션의 꾸준한 유입을 목격하고 있습니다.

미용 주사 시장의 과제와 기회는?

견조한 성장에도 불구하고 미용 주사 시장은 규제, 숙련된 시술자의 필요성, 위조품 및 저품질 제품과 관련된 안전 문제 등의 도전 과제에 직면해 있습니다. 제품 승인 및 관리 기준에 대한 보건 당국의 엄격한 규제는 신규 진입 장벽으로 작용하여 특정 시장에서 특정 주사제의 접근성을 제한합니다. 또한, 주입자의 적절한 교육이나 전문 지식의 부족은 비대칭, 멍, 부작용 등의 합병증을 유발할 수 있으며, 시술에 대한 소비자의 신뢰에 영향을 미칠 수 있습니다. 그러나 이러한 도전은 안전하고 효과적인 사용을 보장하기 위해 전문가 양성 프로그램, 제품 인증, 소비자 교육 활동에 투자할 수 있는 기회를 시장 플레이어에게 제공하고 있습니다. 에스테틱 클리닉과 메디컬 스파의 증가에 힘입어 확대되고 있는 의료 미용 산업은 제조업체들이 프리미엄급 타겟팅 솔루션을 도입할 수 있는 좋은 기회를 제공하고 있습니다. 미용 시술이 빠르게 확산되고 있는 아시아태평양과 라틴아메리카의 신흥 시장 역시 업계 진출 기업들에게 미개척 성장 잠재력을 가지고 있습니다.

미용 주사 시장의 성장을 촉진하는 주요 요인은 무엇인가?

미용 주사 시장의 성장은 비수술적 미용 강화에 대한 수요 증가, 예방적 미용 치료의 채택 증가, 소셜 미디어 및 유명인 추천의 영향력 확대 등 여러 요인에 의해 주도되고 있습니다. 다운타임이 적고, 가격이 저렴하며, 침습적이지 않고 빠르게 시술을 받고자 하는 욕구가 높아지면서 다양한 계층에서 주사제에 대한 수요가 급증하고 있습니다. 또한, 노화 방지 솔루션을 찾는 고령화 사회와 윤곽 성형 및 강화 치료를 선택하는 젊은 세대가 지속적인 시장 성장의 원동력이 되고 있습니다. E-Commerce 플랫폼과 디지털 진료의 확대로 인해 미용 치료에 대한 접근이 더욱 간소화되어 소비자가 사용 가능한 옵션을 쉽게 검토할 수 있게 되었습니다. 미용 기업과 피부과 병원의 공동 연구 개발에 대한 관심이 높아지면서 기술 혁신을 촉진하고 시장에서 사용할 수 있는 주사 가능한 제품의 범위가 확대되고 있습니다. 미용 치료가 사회적 금기를 깨고 주류에 받아들여짐에 따라 미용 주사 시장은 향후 몇 년 동안 지속적인 성장이 예상됩니다.

부문

유형(보툴리눔톡신(보톡스) 미용 주사, 더말 필러 미용 주사), 성별(여성, 남성), 연령층(15-30세, 31-40세, 41-50세, 51-60세, 60세 이상), 최종사용자(병원, 피부과 클리닉, 기타)

조사 대상 기업 사례

  • BIOXIS Pharmaceuticals, SAS
  • Croma-Pharma GmbH
  • Galderma S.A.
  • Laboratoires Vivacy SAS
  • Medytox, Inc.
  • Merz Pharma GmbH & Co. KGaA.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma PLC
  • Teoxane SA
  • Mesoestetic E-commerce S.L.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSM 25.08.13

Global Aesthetic Injectables Market to Reach US$27.3 Billion by 2030

The global market for Aesthetic Injectables estimated at US$15.7 Billion in the year 2024, is expected to reach US$27.3 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Botulinum Toxin Aesthetic Injectables, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$18.0 Billion by the end of the analysis period. Growth in the Dermal Fillers Aesthetic Injectables segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 9.2% CAGR

The Aesthetic Injectables market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Aesthetic Injectables Market - Key Trends & Drivers Summarized

Why Is Demand for Aesthetic Injectables Surging Across the Beauty and Wellness Industry?

The growing emphasis on personal appearance and self-care, driven by social media influence and evolving beauty standards, has significantly propelled the demand for aesthetic injectables. With an increasing number of individuals seeking minimally invasive cosmetic procedures to enhance their facial aesthetics and delay signs of aging, aesthetic injectables have gained widespread acceptance among both younger and older demographics. Botox, dermal fillers, and other injectables are no longer limited to celebrities and high-income groups; their affordability and accessibility have expanded their reach across a broader consumer base. Additionally, the rising awareness of preventive aesthetics, where consumers opt for early intervention treatments to maintain youthful skin, is driving market growth. The increasing acceptance of cosmetic enhancements, coupled with growing disposable incomes and a shift towards non-surgical alternatives, is further fueling demand for aesthetic injectables in various regions.

How Are Technological Advancements and Product Innovations Transforming the Market?

Advancements in formulation technologies and injection techniques are revolutionizing the aesthetic injectables market, making procedures safer, more effective, and longer-lasting. New-generation injectables featuring hyaluronic acid-based fillers, botulinum toxins with improved longevity, and bio-stimulators that promote collagen production are gaining traction among consumers and practitioners alike. These innovations provide more natural-looking results, reducing concerns about over-treatment and enhancing patient satisfaction. Additionally, the advent of micro-cannulas and needle-free injection systems has improved precision and minimized discomfort, further encouraging individuals to opt for these procedures. The integration of artificial intelligence (AI) and 3D imaging technology in aesthetic consultations is also transforming the patient experience, enabling practitioners to customize treatment plans with higher accuracy. With continuous product development focusing on extended duration, improved texture, and reduced side effects, the market is witnessing a steady influx of innovative solutions catering to diverse consumer preferences.

What Are the Challenges and Opportunities in the Aesthetic Injectables Market?

Despite the robust growth, the aesthetic injectables market faces challenges such as regulatory scrutiny, the need for skilled practitioners, and safety concerns associated with counterfeit or low-quality products. Stringent regulations imposed by health authorities regarding product approval and administration standards create barriers for new entrants and limit the availability of certain injectables in specific markets. Moreover, the lack of proper training and expertise among injectors can result in complications such as asymmetry, bruising, or adverse reactions, which may impact consumer trust in the procedure. However, these challenges present opportunities for market players to invest in professional training programs, product certifications, and consumer awareness initiatives to ensure safe and effective use. The expanding medical aesthetics industry, driven by the increasing number of aesthetic clinics and medical spas, offers lucrative opportunities for manufacturers to introduce premium and targeted solutions. Emerging markets in Asia-Pacific and Latin America, where aesthetic procedures are rapidly gaining popularity, also present untapped growth potential for industry participants.

What Are the Key Factors Driving Growth in the Aesthetic Injectables Market?

The growth in the Aesthetic Injectables market is driven by several factors, including the rising demand for non-surgical cosmetic enhancements, increasing adoption of preventive aesthetic treatments, and the expanding influence of social media and celebrity endorsements. The growing inclination towards quick, affordable, and minimally invasive procedures with minimal downtime has led to a surge in demand for injectables across various demographics. Additionally, the aging population seeking anti-aging solutions and the younger generation opting for contouring and enhancement treatments are driving consistent market growth. The expansion of e-commerce platforms and digital consultations has further simplified access to aesthetic treatments, making it easier for consumers to explore available options. The increasing focus on research and development, along with collaborations between aesthetic companies and dermatology clinics, is fostering innovation and expanding the range of injectable products available in the market. As aesthetic treatments continue to break societal taboos and gain mainstream acceptance, the market for aesthetic injectables is expected to witness sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Aesthetic Injectables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Botulinum Toxin Aesthetic Injectables, Dermal Fillers Aesthetic Injectables); Gender (Female Gender, Male Gender); Age Group (15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group, Above 60 Age Group); End-Use (Hospitals End-Use, Dermatology Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • BIOXIS Pharmaceuticals, SAS
  • Croma-Pharma GmbH
  • Galderma S.A.
  • Laboratoires Vivacy SAS
  • Medytox, Inc.
  • Merz Pharma GmbH & Co. KGaA.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma PLC
  • Teoxane SA
  • Mesoestetic E-commerce S.L.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Aesthetic Injectables - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Non-Surgical Cosmetic Procedures Spurs Growth in Aesthetic Injectables Market
    • Growing Popularity of Preventative Aesthetic Treatments Expands Addressable Market for Injectables
    • Advancements in Hyaluronic Acid and Biostimulatory Fillers Enhance Longevity and Efficacy of Treatments
    • Increasing Male Aesthetic Awareness and Treatment Acceptance Drives Growth in the Injectables Segment
    • Surging Influence of Social Media and Celebrity Endorsements Strengthens Demand for Facial Fillers and Neurotoxins
    • Innovations in Painless and Micro-Dosing Injection Techniques Propel Adoption Among First-Time Users
    • Rising Disposable Income and Increased Consumer Spending on Beauty and Wellness Fuel Market Expansion
    • Development of Long-Lasting and Reversible Aesthetic Injectables Creates New Market Opportunities
    • Expanding Applications of Injectables in Medical and Therapeutic Treatments Strengthen Market Position
    • Growing Trend of Combination Therapies with Injectables and Energy-Based Devices Drives Market Growth
    • Regulatory Approvals for New and Next-Generation Neurotoxins Spur Competitive Market Dynamics
    • Increasing Focus on Personalized Aesthetic Treatments Enhances Demand for Tailored Injectable Solutions
    • Expansion of Medical Spas and Non-Surgical Aesthetic Clinics Drives Accessibility and Adoption of Injectables
    • Rising Concerns Over Counterfeit and Unregulated Injectables Create Regulatory and Market Challenges
    • Growing Awareness of Collagen-Boosting Injectables Accelerates Demand for Bio-Regenerative Fillers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Aesthetic Injectables Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Aesthetic Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Botulinum Toxin Aesthetic Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Botulinum Toxin Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Dermal Fillers Aesthetic Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Dermal Fillers Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Dermatology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Dermatology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Female Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Male Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for 15 - 30 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for 15 - 30 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 31 - 40 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for 31 - 40 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for 41 - 50 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for 41 - 50 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for 51 - 60 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for 51 - 60 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Above 60 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Above 60 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • JAPAN
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • CHINA
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • EUROPE
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • FRANCE
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • GERMANY
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • UNITED KINGDOM
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제